Livforsakringsbolaget Skandia’s Quest Diagnostics DGX Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$174K	Hold	889	–	–	0.01%	348
2025 Q4	$154K	Hold	889	–	–	0.01%	389
2025 Q3	$169K	Sell	889 -200	-18%	-$35.5K	0.01%	388
2025 Q2	$195K	Hold	1,089	–	–	0.01%	390
2025 Q1	$184K	Hold	1,089	–	–	0.01%	406
2024 Q4	$164K	Hold	1,089	–	–	0.01%	427
2024 Q3	$169K	Buy	1,089 +778	+250%	+$116K	0.01%	450
2024 Q2	$42.5K	Hold	311	–	–	﹤0.01%	404
2024 Q1	$41.4K	Hold	311	–	–	﹤0.01%	424
2023 Q4	$42.9K	Sell	311 -21,424	-99%	-$2.82M	﹤0.01%	411
2023 Q3	$2.65M	Sell	21,735 -23,700	-52%	-$3.16M	0.29%	88
2023 Q2	$6.38M	Sell	45,435 -4,700	-9%	-$648K	0.66%	44
2023 Q1	$7.09M	Hold	50,135	–	–	0.74%	37
2022 Q4	$7.84M	Hold	50,135	–	–	0.9%	29
2022 Q3	$6.15M	Sell	50,135 -10,900	-18%	-$1.44M	0.76%	35
2022 Q2	$8.12M	Sell	61,035 -400	-0.7%	-$54.5K	0.71%	37
2022 Q1	$8.41M	Hold	61,435	–	–	0.56%	40
2021 Q4	$10.6M	Sell	61,435 -1,400	-2%	-$213K	0.68%	30
2021 Q3	$9.13M	Hold	62,835	–	–	0.57%	35
2021 Q2	$8.29M	Buy	62,835 +4,300	+7%	+$563K	0.49%	46
2021 Q1	$7.51M	Buy	58,535 +8,900	+18%	+$1.1M	0.52%	44
2020 Q4	$5.92M	Hold	49,635	–	–	0.5%	43
2020 Q3	$5.68M	Hold	49,635	–	–	0.61%	38
2020 Q2	$5.66M	Hold	49,635	–	–	0.65%	33
2020 Q1	$3.98M	Buy	49,635 +600	+1%	+$62.1K	0.56%	38
2019 Q4	$5.24M	Sell	49,035 -400	-0.8%	-$41.7K	0.62%	33
2019 Q3	$5.29M	Hold	49,435	–	–	0.63%	32
2019 Q2	$5.03M	Hold	49,435	–	–	0.62%	37
2019 Q1	$4.45M	Hold	49,435	–	–	0.59%	41
2018 Q4	$4.12M	Hold	49,435	–	–	0.62%	40
2018 Q3	$5.33M	Sell	49,435 -11,100	-18%	-$1.22M	0.63%	34
2018 Q2	$6.66M	Hold	60,535	–	–	0.6%	33
2018 Q1	$6.07M	Buy	60,535 +700	+1%	+$71.7K	0.59%	38
2017 Q4	$5.89M	Sell	59,835 -4,300	-7%	-$408K	0.56%	42
2017 Q3	$6.01M	Hold	64,135	–	–	0.54%	44
2017 Q2	$7.13M	Hold	64,135	–	–	0.65%	33
2017 Q1	$6.3M	Sell	64,135 -7,700	-11%	-$734K	0.59%	37
2016 Q4	$6.6K	Buy	71,835 +55,273	+334%	+$4.76M	0.34%	56
2016 Q3	$3.45M	Sell	16,562 -55,273	-77%	-$4.64M	0.17%	155
2016 Q2	$5.85M	Hold	71,835	–	–	0.26%	78
2016 Q1	$5.13M	Hold	71,835	–	–	0.24%	89
2015 Q4	$5.11M	Buy	71,835 +56,400	+365%	+$3.79M	0.24%	97
2015 Q3	$949K	Hold	15,435	–	–	0.05%	444
2015 Q2	$1.12M	Hold	15,435	–	–	0.05%	413
2015 Q1	$1.19M	Sell	15,435 -6,400	-29%	-$458K	0.06%	401
2014 Q4	$1.46M	Hold	21,835	–	–	0.07%	366
2014 Q3	$1.32M	Hold	21,835	–	–	0.05%	431
2014 Q2	$1.28M	Hold	21,835	–	–	0.05%	446
2014 Q1	$1.26M	Buy	+21,835	New	+$1.17M	0.05%	446

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Livforsakringsbolaget Skandia's DGX Position: Q1 2026 in Review

Livforsakringsbolaget Skandia held its Quest Diagnostics (DGX) position steady in Q1 2026 at 889 shares worth $174K. The position accounts for 0.01% of the portfolio, ranked #348.

Livforsakringsbolaget Skandia first reported a position in DGX in Q1 2014 and has held it in 49 quarters since. The position peaked at $10.6M in Q4 2021. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Livforsakringsbolaget Skandia held 889 shares of Quest Diagnostics worth $174K as of Q1 2026.
Livforsakringsbolaget Skandia left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up 0.01% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #348 holding.
Livforsakringsbolaget Skandia first reported a position in Quest Diagnostics in Q1 2014 and has held it in 49 quarters since.
Livforsakringsbolaget Skandia's Quest Diagnostics position peaked at $10.6M in Q4 2021.
1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.